N-methyl-D-aspartate receptor subunit NR1 (NR1)

The N-methyl-D-aspartate (NMDA) receptor subunit NR1 glycine co-agonist site is a specialized binding pocket located on the GluN1 (NR1) subunit of the NMDA receptor complex (StatPearls) [10]. This site is unique because it requires the binding of a co-agonist, typically glycine or D-serine, as an absolute prerequisite for the receptor's ion channel to open in response to glutamate (PubMed) [11]. Functioning as a coincidence detector, the NMDA receptor mediates calcium influx that is vital for synaptic plasticity, learning, and memory (Wikipedia) [19]. In clinical contexts, hypofunction of this site is linked to the cognitive and negative symptoms of schizophrenia, leading to the development of glycine site agonists and GlyT1 inhibitors to boost its activation (Frontiers) [4]. Conversely, over-activation of the receptor can lead to excitotoxic neuronal death, making the site a target for antagonists in conditions like stroke or chronic pain (PubMed) [16]. Despite its therapeutic potential, drug development is complicated by the need for precise modulation to avoid side effects like psychosis or neurotoxicity (PMC) [9].

Other names

Glycine modulatory siteNMDA receptor glycine siteStrychnine-insensitive glycine binding siteGluN1GRIN1NMDA receptor subunit 1

The glycine co-agonist site on the NR1 subunit must be occupied by glycine or D-serine for the NMDA receptor ion channel to open in response to glutamate binding and membrane depolarization (PubMed) [11].